Skip to main content

iwCLL 2023 Main banner

iwCLL X / Twitter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

John M. Burke, MD

Associate Chair, US Oncology Research Program
Rocky Mountain Cancer Centers, US Oncology Research

n/a

Poster(s):

2009 - A phase 2 study of zanubrutinib in previously treated B-cell malignancies intolerant to ibrutinib and/or acalabrutinib: preliminary results for patients with CLL/SLL